Ontology highlight
ABSTRACT: Objective
Changing cardiac troponin (cTn) assays may affect a hospital's admission and myocardial infarction rates. The effect of changing from a contemporary to high-sensitivity (hs) cTnI assay has been well described, but the real-life impact on disposition and diagnosis of changing from one hs-cTnI assay to another has not.Methods
All patients who received a troponin measurement in the ED during 16 weeks were adjudicated to identify those the attending physician investigated for possible acute coronary syndrome (ACS) and for clinical outcomes. The Abbott ARCHITECT hs-cTnI assay was in use for the first 8 weeks, followed by the Beckman Coulter hs-cTnI assay for the second 8 weeks.Results
Fewer patients were investigated with the Abbott assay (2213), than the Beckm
SUBMITTER: Pickering JW
PROVIDER: S-EPMC11876939 | biostudies-literature | 2025 Apr
REPOSITORIES: biostudies-literature